Goebell P - Search Results

1

Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.

Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, Goebell P, Schmitz-Drager B, Todenhofer T, Black PC, Kamat AM, Williams SB. Hensley PJ, et al. Among authors: goebell p. Urol Oncol. 2023 Jul;41(7):307-312. doi: 10.1016/j.urolonc.2023.01.001. Epub 2023 Jan 25. Urol Oncol. 2023. PMID: 36702704 Review.

2

[Guideline adherence].

Krege S, Goebell PJ. Krege S, et al. Among authors: goebell pj. Urologe A. 2019 Sep;58(9):1016-1018. doi: 10.1007/s00120-019-0994-2. Urologe A. 2019. PMID: 31451880 German. No abstract available.

3

Environmental exposure, chlorinated drinking water, and bladder cancer.

Goebell PJ, Villanueva CM, Rettenmeier AW, Rübben H, Kogevinas M. Goebell PJ, et al. World J Urol. 2004 Feb;21(6):424-32. doi: 10.1007/s00345-003-0389-1. Epub 2003 Dec 20. World J Urol. 2004. PMID: 14689225

4

[Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study].

Rose A, Suttor S, Goebell PJ, Rossi R, Rübben H. Rose A, et al. Among authors: goebell pj. Urologe A. 2007 Sep;46(9):1148-50. doi: 10.1007/s00120-007-1391-9. Urologe A. 2007. PMID: 17619851 Clinical Trial. German.

5

Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.

Bergmann L, Kube U, Doehn C, Steiner T, Goebell PJ, Kindler M, Herrmann E, Janssen J, Weikert S, Scheffler MT, Schmitz J, Albrecht M, Staehler M. Bergmann L, et al. BMC Cancer. 2015 Apr 18;15:303. doi: 10.1186/s12885-015-1309-7. BMC Cancer. 2015. PMID: 25925846 Free PMC article. Clinical Trial.

6

Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment.

Otto T, Goebell PJ, Rübben H. Otto T, et al. Among authors: goebell pj. Onkologie. 2003 Oct;26(5):484-8. doi: 10.1159/000072983. Onkologie. 2003. PMID: 14605467 Review.

7

Tumor cell motility as a novel target in cancer--experimental and clinical results.

Otto T, Luemmen G, Bex A, Suhr J, Goebell PJ, Raz A, Ruebben H. Otto T, et al. Among authors: goebell pj. Onkologie. 2002 Apr;25(2):172-7. doi: 10.1159/000055228. Onkologie. 2002. PMID: 12006769

8

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.

Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, O'Hagan A, Avadhani A, Siefker-Radtke AO; BLC2001 Study Group. Loriot Y, et al. N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323. N Engl J Med. 2019. PMID: 31340094 Clinical Trial.

9

Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.

Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA. Franke KH, et al. Among authors: goebell p. Urology. 2000 Oct 1;56(4):689-95. doi: 10.1016/s0090-4295(00)00678-6. Urology. 2000. PMID: 11018640

10

Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.

Oosterlinck W, Solsona E, Akaza H, Busch C, Goebell PJ, Malmström PU, Ozen H, Sved P. Oosterlinck W, et al. Among authors: goebell pj. Urology. 2005 Dec;66(6 Suppl 1):75-89. doi: 10.1016/j.urology.2005.07.063. Urology. 2005. PMID: 16399417 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page